Zebra Medical Vision's Chief Medical Officer, Dr. Orit Wimpfheimer, on the future of radiology and how to juggle a high-flying career with being a mom of nine Dr. Orit Wimpfheimer is a diagnostic radiologist who founded her Israel-based teleradiology company in 2001. She joined Zebra Medical Vision, initially as clinical director, and now as chief medical officer, bringing her experience to direct and promote AI technology. What initially sparked your interest in medicine and subsequently, AI in medicine? I came from a family of doctors. My father, uncle and two brothers were all doctors, so I grew up in a family where medicine was central to many of our conversations around the dinner table.

AI can reduce the need for CT scans, which expose patients to higher levels of radiation than other ... [ ] imaging techniques. AI's potential in medicine has already attracted large amounts of media and public attention. However, some of the specific uses and consequences of AI in the context of health care aren't particularly well known, at least not compared to awareness of the general utility of artificial intelligence. Some of these uses may be life-saving, and in more ways than one. In recent months, a small number of companies and researchers have begun using AI for the purposes of medical imaging, harnessing machine learning algorithms in order to construct 3D models out of 2D images.

Israeli MedTech companies have experienced quite the acceleration process following the COVID-19 outbreak, with digital health companies garnering the bulk of the focus. The AI medical train has left the station with companies like Ibex Medical, Aidoc, Scopio, and more all scoring funding and coveted FDA approvals this year. However, in the land of medical-AI FDA clearances, one horse stands alone, or should I say Zebra. Israeli startup Zebra Medical Vision, the deep-learning medical imaging analytics company, announces today its seventh FDA clearance. The newly approved solution utilizes the power of AI to extract bone measurements from X-ray scans, similar in quality to CT scans, for the purpose of planning orthopedic surgical procedures.

In the news this week: A bevy of partnerships to bring artificial intelligence (AI) and machine learning (ML) to medical applications, and more. Keeping pace with news and developments in the real-time analytics market can be a daunting task. We want to help by providing a summary of some of the items our staff came across each week. The use of artificial intelligence (AI) and machine learning (ML) in healthcare and medical diagnosis is perhaps one of the most promising applications of the technology for the public good. Frequently, the main inhibitor to the use of AI in these fields is the lack of internal familiarity with the technology.

Latest AI/Machine Learning Market report evaluates the impact of Covid-19 outbreak on the industry, involving potential opportunity and challenges, drivers and risks and market growth forecast based on different scenario. Global AI/Machine Learning industry Market Report is a professional and in-depth research report on the world's major regional market. Top Players Listed in the AI/Machine Learning Market Report are GOOGLE, IBM, BAIDU, SOUNDHOUND, ZEBRA MEDICAL VISION, PRISMA, IRIS AI, PINTEREST, TRADEMARKVISION, DESCARTES LABS, Amazon. AI/Machine Learning market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Based on type, report split into TensorFlow, Caffe2, Apache MXNet.

Zebra Medical Vision, the deep-learning medical imaging analytics company, announced on Monday that it secured its 5th FDA clearance, this time for an AI solution that identifies findings suggestive of compression fractures in scans. The Israeli firm said the FDA gave 510(k) clearance for its Vertebral Compression Fractures (VCF) product that enables clinicians to place patients at risk of osteoporosis "in treatment pathways to prevent potentially life-changing fractures," Zebra Medical said in a statement. The solution can be applied to abdominal or chest CT scan performed for any clinical indication, the company says. Founded in 2014 by Eyal Toledano, Eyal Gura, and Elad Benjamin, Zebra uses AI to read medical scans and automatically detect anomalies. Through its development and use of different algorithms, Zebra Medical has been able to identify visual symptoms for diseases such as breast cancer, osteoporosis, and fatty liver, as well as conditions such as aneurysms and brain bleeds.

Zebra's Imaging Analytics Engine receives imaging scans from various modalities and automatically analyzes them for a number of different clinical findings, in a timely manner and full synergy with radiology workflow. Zebra uses a proprietary database of millions of imaging scans, along with machine and deep learning tools, to create software that analyzes data in real time with human level accuracy – providing radiologists the assistance they need to manage ever growing workloads, without sacrificing quality. Providers use Zebra to alert them of patients at high risk of cardiovascular, lung, bone and other diseases. With Zebra – focus can be provided to the right patients, at the right time – saving overall costs while improving care. Our Imaging Analytics Engine uncovers brain, lung, liver, cardiovascular and bone disease in CT scans, 40 different conditions in X-rays scans, and breast cancer in 2D mammograms with an ever growing pipeline.

Israel's Zebra Medical Vision has teamed up with Johnson & Johnson subsidiary DePuy Synthes to jointly bring cloud-based AI solutions to the orthopaedic and bone health industry. Under the partnership, Zebra Medical Vision's machine learning algorithms will be used to create three-dimensional models of patients from X-ray images. Conventional orthopaedic procedures are based on two-dimensional CT scans or MRI imaging to assist with pre-operative planning. However, CT scans and MRI imaging can be expensive, associated with more radiation and are painful for some patients. Zebra Medical Vision co-founder and CEO Eyal Gura said: "We are thrilled to start this collaboration and have the opportunity to impact and improve orthopaedic procedures and outcomes in areas including the knee, hip, shoulder, trauma, and spine care.

About Us: With unfailing market gauging skills, Orbis Market Reports has been excelling in curating tailored business intelligence data across industry verticals. Constantly thriving to expand our skill development, our strength lies in dedicated intellectuals with dynamic problem-solving intent, ever willing to mold boundaries to scale heights in market interpretation.

AI's potential in medicine has already attracted large amounts of media and public attention. However, some of the specific uses and consequences of AI in the context of health care aren't particularly well known, at least not compared to awareness of the general utility of artificial intelligence. Some of these uses may be life-saving, and in more ways than one. In recent months, a small number of companies and researchers have begun using AI for the purposes of medical imaging, harnessing machine learning algorithms in order to construct 3D models out of 2D images. This may seem like a fairly standard employment of AI at first glance, but what's special about this emerging use is that it's focused on avoiding the need for MRI, CT and PET scans.